Medical device makers last year were less affected by the medical device tax than they had anticipated. Fewer reported negative impacts and more reported no impact at all, according to an annual industry survey.
2014
Varian misses analysts’ estimates but is on track for 2014
Palo Alto, Calif.-based Varian Medical (NYSE:VAR) started its fiscal year with moderate growth and a reaffirmed outlook on 2014, but per-share earnings fall short of analysts’ projections.
CareFusion affirms full-year outlook amid 10% profit slide in Q2
Analysts are taking a cautious approach to CareFusion (NYSE:CFN) amid increasing costs and a 10% drip in profits for the company’s 2nd quarter.
Hologic swings to a loss but beats The Street
Accuray soars on Street-beating Q2 and increased guidance
Abiomed hits record highs in Q3 with Impella sales up 20%
Siemens soars but healthcare biz takes a hit
Haemonetics’ streamlining efforts boost Q3 profits by 64%
Massachusetts medical device maker Haemonetics (NYSE:HAE) this week released its 3rd-quarter earnings report, posting a major boost in profits that the company attributed to "productivity programs yielding cost efficiencies."
Covidien reports 19% profit dip and notches a win in J&J patent battle
Investors balk at J&J’s 2014 guidance despite Q4, 2013 growth
Johnson & Johnson (NYSE:JNJ) shares are down this morning after the healthcare conglomerate said it expects its 2014 earnings to be a penny below expectations and posted strong sales and profit growth for the 4th quarter and 2013.